Move your hits to candidates faster with Axcelead
Axcelead delivers quality with speed. We maintain an 84% client …
Irbesartan but not Roflumilast Ameliorates Renal Injury in a Col4a5 R471* Mutant Mouse Model of Alport Syndrome and CKD
The World Congress of Nephrology 2026
Inducible Exon Skipping After Disease Onset as a Therapeutic Strategy for CKD：Evaluation in a Patient-Derived Mouse Model of Alport Syndrome
The World Congress of Nephrology 2026
Co-authored Paper by Researcher Matsumoto and Researcher Miura of the Translational Research Business Unit Published in Gut Pathogens
Cross-organ multi-omics profiling of microbiome and metabolome along …
Researcher Yamamoto from Pharmacology Business Unit to Present a Poster at the World Congress of Nephrology 2026
Researcher Yamamoto from Pharmacology Business Unit, will deliver …
Researcher Hashikami from Pharmacology Business Unit to Present a Poster at the World Congress of Nephrology 2026
Researcher Hashikami from Pharmacology Business Unit , will …
Proteros and Axcelead DDP Enter Strategic Collaboration to Enhance Discovery Capabilities
Proteros and Axcelead DDP Enter Strategic Collaboration to …
A co-authored paper by researcher Miura of the DMPK & Safety Business Unit was published in Metabolites
Investigation of storage conditions and quality control markers …
Dr. Hirano from Screening Business Unit will give an oral presentation at the symposium of the 99th Annual Meeting of the Japanese Pharmacological Society
Dr. Hirano from the Screening Business Unit, will …